Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

November 30, 2010

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
PainLow Back Pain
Interventions
DRUG

Buprenorphine

buccal soluble film; applied to the buccal mucosa twice daily

DRUG

Placebo

buccal soluble film; applied to the buccal mucosa twice daily

Trial Locations (24)

10022

Research Across American, New York

16602

Allegheny Pain Management, Altoona

27103

The Center for Clinical Research, LLC, Winston-Salem

27612

Wake Research Associates, LLC, Raleigh

30060

Taylor Research, LLC, Marietta

32129

Accord Clinical Research, LLC, Port Orange

32720

Avail Clinical Research, LLC, DeLand

33317

Gold Coast Research, LLC, Plantation

33458

Health Awareness, Inc., Jupiter

35209

Alabama Orthopaedic Center - Research, Birmingham

36608

Coastal Clinical Research, Inc., Mobile

47714

MediSphere Medical Research Center, LLC, Evansville

61701

Millennium Pain Center, Bloomington

66211

International Clinical Research Institute, Leawood

78731

FutureSearch Trials of Neurology, Austin

79902

Southwest Urgent Care Center, El Paso

84088

Advanced Clinical Research, West Jordan

84106

Lifetree Clinical Research, Salt Lake City

85023

Arizona Research Center, Phoenix

89144

Office of Stephen H. Miller, MD, Las Vegas

90806

Collaborative Neuroscience Network, Inc., Long Beach

92037

University of California, San Diego Medical Center, UCSD Center for Pain Medicine, La Jolla

93710

Neuro-Pain Medical Center, Fresno

02472

MedVadis Research Corporation, Watertown

All Listed Sponsors
lead

BioDelivery Sciences International

INDUSTRY